10x Genomics, Inc.
TXGFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
611
Cost of Revenue
196
Gross Profit
414
Gross Margin
67.9%
Operating Income
-195
Operating Margin
-31.9%
Net Income
-183
Net Margin
-29.9%
EPS (Basic)
$-1.52
EPS (Diluted)
$-1.52
EBITDA
-134
EBITDA Margin
-21.9%
2023
12/31/2023
Revenue
619
Cost of Revenue
209
Gross Profit
409
Gross Margin
66.2%
Operating Income
-265
Operating Margin
-42.9%
Net Income
-255
Net Margin
-41.2%
EPS (Basic)
$-2.18
EPS (Diluted)
$-2.18
EBITDA
-205
EBITDA Margin
-33.2%
2022
12/31/2022
Revenue
516
Cost of Revenue
120
Gross Profit
396
Gross Margin
76.7%
Operating Income
-168
Operating Margin
-32.5%
Net Income
-166
Net Margin
-32.1%
EPS (Basic)
$-1.46
EPS (Diluted)
$-1.46
EBITDA
-128
EBITDA Margin
-24.9%
2021
12/31/2021
Revenue
490
Cost of Revenue
74
Gross Profit
416
Gross Margin
84.9%
Operating Income
-53
Operating Margin
-10.8%
Net Income
-58
Net Margin
-11.9%
EPS (Basic)
$-0.53
EPS (Diluted)
$-0.53
EBITDA
-25
EBITDA Margin
-5.0%
2020
12/31/2020
Revenue
299
Cost of Revenue
58
Gross Profit
240
Gross Margin
80.4%
Operating Income
-85
Operating Margin
-28.6%
Net Income
-543
Net Margin
-181.6%
EPS (Basic)
$-5.37
EPS (Diluted)
$-5.37
EBITDA
-514
EBITDA Margin
-171.9%